Product Information
GEMFIBROZIL 600 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1034 per EA under NDC 16571078406. Its NADAC has been published 234 times since Jan 5, 2022.
Strength
600 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571078406
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GEMFIBROZILApproval Type
Generic (ANDA)
FDA Application
ANDA202726On Market Since
9/16/2015
Pharmacological Classes
Price Statistics
The NADAC for GEMFIBROZIL 600 MG TABLET has been published 234 times since Jan 5, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1034 per EA |
|---|---|
| All-time high | $0.1135 (Feb 14, 2024) |
| All-time low | $0.0871 (Nov 20, 2024) |
| 52-week high | $0.1075 |
| 52-week low | $0.1005 |
| Median price | $0.1043 |
| Average price | $0.1038 |
| Largest weekly change | -18.6% (Apr 17, 2024) |
| Weeks tracked | 234 |
| Tracking since | Jan 5, 2022 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GEMFIBROZIL 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1034 per EA (NDC 16571078406), effective Jun 24, 2026.
How has the price of GEMFIBROZIL 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has held within roughly two percent of its current level. It has been tracked across 234 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?
Since Jan 5, 2022, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0871 (Nov 20, 2024) to a high of $0.1135 (Feb 14, 2024), with a median of $0.1043 per EA.
Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 14% below GEMFIBROZIL 600 MG TABLET.
Who manufactures GEMFIBROZIL 600 MG TABLET?
GEMFIBROZIL 600 MG TABLET (NDC 16571078406) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification